Schedule of stock option activity |
|
|
Outstanding
share options |
|
|
Weighted-
average
exercise
price ($) |
|
|
Weighted
average
remaining
contractual
life (years) |
|
|
Aggregate
intrinsic
value ($ in
thousands) |
|
Options: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2019 |
|
|
3,555,804 |
|
|
|
0.652 |
|
|
|
5.024 |
|
|
|
109,779 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted |
|
|
932,835 |
|
|
|
1.199 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(494,450 |
) |
|
|
1.042 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(226,155 |
) |
|
|
0.132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2020 |
|
|
3,768,034 |
|
|
|
0.767 |
|
|
|
4.626 |
|
|
|
119,146 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted |
|
|
1,966,916 |
|
|
|
7.250 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(117,863 |
) |
|
|
0.972 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(155,750 |
) |
|
|
0.602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2021 |
|
|
5,461,337 |
|
|
|
3.102 |
|
|
|
5.363 |
|
|
|
16,713,971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Granted |
|
|
1,630,142 |
|
|
|
6.833 |
|
|
|
|
|
|
|
|
|
Forfeited |
|
|
(468,814 |
) |
|
|
5.557 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(570,451 |
) |
|
|
0.482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2022 |
|
|
6,052,214 |
|
|
|
4.166 |
|
|
|
5.570 |
|
|
|
7,761,705 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable as of December 31, 2022 |
|
|
3,322,177 |
|
|
|
2.073 |
|
|
|
3.586 |
|
|
|
7,039,511 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options available for future grants |
|
|
1,423,623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schedule of RSUs activity |
|
|
Numbers of
RSUs |
|
RSUs: |
|
|
|
|
|
|
|
Outstanding as of January 1, 2021 |
|
|
- |
|
|
|
|
|
|
Granted |
|
|
1,968,974 |
|
Forfeited |
|
|
- |
|
Vested |
|
|
- |
|
|
|
|
|
|
Outstanding as of December 31, 2021 |
|
|
1,968,974 |
|
|
|
|
|
|
Granted |
|
|
1,619,898 |
|
Forfeited |
|
|
(417,025 |
) |
Vested |
|
|
(573,583 |
) |
|
|
|
|
|
Outstanding as of December 31, 2022 |
|
|
2,598,084 |
|
|
Schedule of share based compensation expense |
|
|
Year ended December 31 |
|
|
|
2022 |
|
|
2021 |
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
$ |
5,726 |
|
|
$ |
1,518 |
|
|
$ |
320 |
|
Sales and marketing |
|
|
1,403 |
|
|
|
217 |
|
|
|
65 |
|
General and administrative |
|
|
1,537 |
|
|
|
419 |
|
|
|
46 |
|
Cost of revenues |
|
|
127 |
|
|
|
57 |
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense |
|
$ |
8,793 |
|
|
$ |
2,211 |
|
|
$ |
439 |
|
|